[Management of chologenic diarrhea and steatorrhea in the enteral bile acid losing syndrome using cholestyramine and medium-chain triglycerides].
D000328:Adult; D001647:Bile Acids and Salts / Q000096:biosynthesis / Q000378:metabolism*; D001660:Biliary Tract Diseases / Q000150:complications*; D002446:Celiac Disease / Q000188:drug therapy*; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D003424:Crohn Disease / Q000601:surgery; D003967:Diarrhea / Q000188:drug therapy*; D004386:Duodenum / Q000378:metabolism; D005243:Feces / Q000032:analysis; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D007583:Jejunum / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy; D014280:Triglycerides / Q000627:therapeutic use*
D001647:Bile Acids and Salts; D014280:Triglycerides; D002792:Cholestyramine Resin
Die Behandlung der chologenen Diarrhoe und Steatorrhoe des enteralen Gallensäureverlustsyndroms mit Cholestyramin und mittelkettigen Triglyceriden.